Symbols / NDRA $4.69 -0.01% ENDRA Life Sciences Inc.

Healthcare • Diagnostics & Research • United States • NCM
NDRA Chart
About

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Diagnostics & Research Market Cap 7.02M
Enterprise Value 5.55M Income -7.03M Sales —
Book/sh 0.22 Cash/sh 0.61 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E 0.24 Forward P/E -1.02 PEG —
P/S — P/B 21.51 P/C —
EV/EBITDA -0.97 EV/Sales — Quick Ratio 1.01
Current Ratio 1.29 Debt/Eq 21.78 LT Debt/Eq —
EPS (ttm) -8.93 EPS next Y -4.62 EPS Growth —
Revenue Growth — Earnings 2026-03-31 16:00 ROA -86.73%
ROE -291.56% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 1.50M
Shs Float 1.17M Short Float 4.92% Short Ratio 0.19
Short Interest — 52W High 11.96 52W Low 2.90
Beta — Avg Volume 113.79K Volume 779.00
Target Price $30.00 Recom None Prev Close $4.69
Price $4.69 Change -0.01%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$30.00
Mean price target
2. Current target
$4.51
Latest analyst target
3. DCF / Fair value
$-74.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.51
Low
$30.00
High
$30.00
Mean
$30.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-08 main Ascendiant Capital Buy → Buy $30
2025-09-22 main Ascendiant Capital Buy → Buy $38
2025-05-30 main Ascendiant Capital Buy → Buy $46
2025-04-21 main Ascendiant Capital Buy → Buy $50
2024-06-07 main Ascendiant Capital Buy → Buy $8
2023-03-31 reit HC Wainwright & Co. — → Buy $9
News
RSS: Latest NDRA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 TOKMAN ALEXANDER Y Chief Executive Officer — 26,921 $0.00 $0
2026-03-02 JACROUX RICHARD Chief Financial Officer — 13,461 $0.00 $0
2026-01-21 DIGIANDOMENICO ANTHONY Director — 60,324 $0.00 $0
2026-01-21 TOKMAN ALEXANDER Y Chief Executive Officer — 75,000 $0.00 $0
2026-01-21 HARSH MICHAEL JOHN Director — 60,324 $0.00 $0
2026-01-21 BASENESE LOUIS J. Director — 60,324 $0.00 $0
2026-01-21 JACROUX RICHARD Chief Financial Officer — 20,000 $0.00 $0
2025-10-10 DIGIANDOMENICO ANTHONY Director — 70,822 $7.06 $500,003
2025-06-11 DIGIANDOMENICO ANTHONY Director — 5,384 $0.00 $0
2025-06-11 HARSH MICHAEL JOHN Director — 5,384 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Gross Profit
—
—
—
—
Operating Expense
5.76
-46.72%
10.82
+2.82%
10.52
-20.04%
13.16
Research And Development
1.85
-42.01%
3.19
-36.24%
5.00
-23.66%
6.55
Selling General And Administration
3.91
-48.69%
7.63
+38.24%
5.52
-16.45%
6.60
Selling And Marketing Expense
0.19
-66.82%
0.57
-30.41%
0.82
-42.58%
1.43
General And Administrative Expense
3.72
-47.23%
7.06
+50.24%
4.70
-9.23%
5.17
Other Gand A
3.72
-47.23%
7.06
+50.24%
4.70
-9.23%
5.17
Total Expenses
5.76
-46.72%
10.82
+2.82%
10.52
-20.04%
13.16
Operating Income
-5.76
+46.72%
-10.82
-2.82%
-10.52
+20.04%
-13.16
Total Operating Income As Reported
-5.76
+46.72%
-10.82
-2.82%
-10.52
+20.04%
-13.16
EBITDA
-5.61
+47.17%
-10.61
-3.57%
-10.25
+20.72%
-12.92
Normalized EBITDA
-4.27
+56.53%
-9.81
+4.23%
-10.25
+20.72%
-12.92
Reconciled Depreciation
0.16
-23.71%
0.21
-25.15%
0.28
+17.58%
0.23
EBIT
-5.76
+46.72%
-10.82
-2.82%
-10.52
+20.04%
-13.16
Total Unusual Items
-1.34
-67.73%
-0.80
—
0.00
Total Unusual Items Excluding Goodwill
-1.34
-67.73%
-0.80
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Pretax Income
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Net Non Operating Interest Income Expense
—
-7.32
—
—
Interest Expense Non Operating
—
—
—
—
Net Interest Income
—
-7.32
—
—
Interest Expense
—
—
—
—
Other Income Expense
-1.26
-83.02%
-0.69
-250.02%
0.46
+2238.51%
-0.02
Other Non Operating Income Expenses
0.08
-29.63%
0.11
-76.44%
0.46
+2238.51%
-0.02
Gain On Sale Of Security
-1.34
-67.73%
-0.80
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Net Income From Continuing Operation Net Minority Interest
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Net Income From Continuing And Discontinued Operation
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Net Income Continuous Operations
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Normalized Income
-5.69
+46.90%
-10.71
-6.45%
-10.06
+23.67%
-13.18
Net Income Common Stockholders
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-8.93
+84.32%
-56.94
+97.94%
-2,766.85
+65.33%
-7,980.00
Basic EPS
-8.93
+84.32%
-56.94
+97.94%
-2,766.85
+65.33%
-7,980.00
Basic Average Shares
0.79
+289.41%
0.20
+5458.47%
0.00
+120.10%
0.00
Diluted Average Shares
0.79
+289.41%
0.20
+5458.47%
0.00
+120.10%
0.00
Diluted NI Availto Com Stockholders
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Total Other Finance Cost
—
7.32
—
—
Line Item Trend 2022-12-31 2021-12-31
Total Assets
9.27
—
Current Assets
5.38
—
Cash Cash Equivalents And Short Term Investments
4.89
—
Cash And Cash Equivalents
4.89
—
Cash Financial
4.89
—
Inventory
2.64
+105.88%
1.28
Raw Materials
—
1.28
Prepaid Assets
0.49
—
Total Non Current Assets
3.89
—
Net PPE
0.74
—
Gross PPE
1.39
—
Accumulated Depreciation
-0.64
—
Properties
0.74
—
Construction In Progress
0.14
—
Other Properties
0.51
—
Non Current Prepaid Assets
0.50
—
Other Non Current Assets
2.65
—
Total Liabilities Net Minority Interest
2.07
—
Current Liabilities
1.70
—
Payables And Accrued Expenses
0.83
—
Payables
0.61
—
Accounts Payable
0.61
—
Current Accrued Expenses
0.22
—
Pensionand Other Post Retirement Benefit Plans Current
0.69
—
Current Debt And Capital Lease Obligation
0.18
—
Current Debt
0.03
—
Other Current Borrowings
0.03
—
Current Capital Lease Obligation
0.15
—
Total Non Current Liabilities Net Minority Interest
0.37
—
Long Term Debt And Capital Lease Obligation
0.37
—
Long Term Debt
—
0.03
Long Term Capital Lease Obligation
0.37
—
Stockholders Equity
7.20
—
Common Stock Equity
7.20
—
Capital Stock
0.00
—
Common Stock
0.00
—
Preferred Stock
0.00
—
Share Issued
0.00
—
Ordinary Shares Number
0.00
—
Additional Paid In Capital
89.07
—
Retained Earnings
-81.87
—
Total Equity Gross Minority Interest
7.20
—
Total Capitalization
7.20
—
Working Capital
3.68
—
Invested Capital
7.23
—
Total Debt
0.55
—
Capital Lease Obligations
0.52
—
Net Tangible Assets
7.20
—
Tangible Book Value
7.20
—
Derivative Product Liabilities
—
—
Other Equity Interest
0.01
-56.19%
0.01
Preferred Shares Number
0.00
+0.00%
0.00
Preferred Stock Equity
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.18
+29.97%
-7.40
+22.50%
-9.55
+25.22%
-12.77
Cash Flow From Continuing Operating Activities
-5.18
+29.97%
-7.40
+22.50%
-9.55
+25.22%
-12.77
Net Income From Continuing Operations
-7.03
+38.93%
-11.51
-14.39%
-10.06
+23.67%
-13.18
Depreciation Amortization Depletion
0.16
-23.71%
0.21
-25.15%
0.28
+17.58%
0.23
Depreciation
0.16
-23.71%
0.21
-25.15%
0.28
+17.58%
0.23
Depreciation And Amortization
0.16
-23.71%
0.21
-25.15%
0.28
+17.58%
0.23
Other Non Cash Items
-0.01
-512000.00%
-0.00
—
—
Stock Based Compensation
0.33
-42.40%
0.57
-42.60%
1.00
-16.95%
1.20
Provisionand Write Offof Assets
0.00
-100.00%
2.39
+1629.24%
0.14
0.00
Asset Impairment Charge
0.00
-100.00%
0.01
-64.58%
0.02
+1687.78%
0.00
Operating Gains Losses
0.35
-56.77%
0.80
—
—
Gain Loss On Investment Securities
0.35
-56.77%
0.80
—
—
Unrealized Gain Loss On Investment Securities
1.00
0.00
—
—
Change In Working Capital
0.02
-83.13%
0.13
+114.52%
-0.92
+9.99%
-1.03
Change In Inventory
0.00
-100.00%
0.24
+302.88%
-0.12
+91.46%
-1.36
Change In Prepaid Assets
-0.00
-100.55%
0.26
+52.91%
0.17
-52.87%
0.36
Change In Payables And Accrued Expense
0.11
+156.97%
-0.20
+75.81%
-0.82
-836.96%
0.11
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
-0.09
+43.76%
-0.16
-4.25%
-0.15
-15.04%
-0.13
Investing Cash Flow
-3.02
-23479.87%
-0.01
+48.24%
-0.02
+87.80%
-0.20
Cash Flow From Continuing Investing Activities
-3.02
-23479.87%
-0.01
+48.24%
-0.02
+87.80%
-0.20
Net PPE Purchase And Sale
-0.02
-35.04%
-0.01
+48.24%
-0.02
+87.80%
-0.20
Purchase Of PPE
-0.02
-8.00%
-0.02
+52.78%
-0.03
+83.27%
-0.20
Sale Of PPE
0.00
-100.00%
0.00
-65.03%
0.01
0.00
Capital Expenditure
-3.02
-18758.00%
-0.02
+52.78%
-0.03
+83.27%
-0.20
Net Intangibles Purchase And Sale
-3.00
0.00
—
—
Purchase Of Intangibles
-3.00
0.00
—
—
Financing Cash Flow
5.73
-26.59%
7.81
+3.87%
7.52
-10.49%
8.40
Cash Flow From Continuing Financing Activities
5.73
-26.59%
7.81
+3.87%
7.52
-10.49%
8.40
Net Issuance Payments Of Debt
0.00
+100.00%
-0.03
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
0.00
+100.00%
-0.03
—
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
0.00
+100.00%
-0.03
—
—
Net Long Term Debt Issuance
0.00
+100.00%
-0.03
—
—
Short Term Debt Payments
—
-0.03
—
—
Net Short Term Debt Issuance
—
-0.03
—
—
Net Common Stock Issuance
5.73
-12.03%
6.52
+0.52%
6.48
-22.81%
8.40
Proceeds From Stock Option Exercised
0.00
-100.00%
1.32
+27.60%
1.03
0.00
Net Other Financing Charges
—
0.00
—
—
Changes In Cash
-2.47
-723.68%
0.40
+119.25%
-2.06
+55.05%
-4.57
Beginning Cash Position
3.23
+13.96%
2.83
-42.04%
4.89
-48.33%
9.46
End Cash Position
0.76
-76.39%
3.23
+13.96%
2.83
-42.04%
4.89
Free Cash Flow
-8.20
-10.56%
-7.42
+22.60%
-9.58
+26.13%
-12.97
Interest Paid Supplemental Data
0.06
+75.02%
0.03
-29.07%
0.04
-23.90%
0.06
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
5.73
-12.03%
6.52
+0.52%
6.48
-22.81%
8.40
Issuance Of Capital Stock
5.73
-12.03%
6.52
+0.52%
6.48
-22.81%
8.40
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category